Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2026-01-20

FDA Approved: ZIRGAN — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for ZIRGAN (ganciclovir ophthalmic gel) from Bausch & Lomb Incorporated, resulting in labeling changes related to it…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZIRGAN (GANCICLOVIR)

Snippet

SUPPL AP for ZIRGAN (GANCICLOVIR)